AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study-Reference-Cited by-同舟云学术

AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study

Published:2021-09 Issue: Volume: Page:100994
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Avagimyan Ashot,Mkrtchyan Lusine,Abrahomovich Orest,Sheibani Mohammad,Guevorkyan Astkhik,Sarrafzadegan Nizal^ORCID,Kozhukhov Sergey,Agati Luciano,Astengiano Ricardo,Zaritska Valentina,Jndoyan Zinaida

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference16 articles.

1. Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018;Anker;ESC Heart Fail,2018

2. Cardiotoxicity of chemotherapy: case report and literature review;Avagimyan;Lviv Clinical Bulletin,2019

3. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry;López-Sendón;Eur Heart J,2020

4. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations;Curigliano;Ann Oncol,2020

5. Anthracycline associated disturbances of cardiovascular homeostatsis;Avagimyan;Current Problems of Cardiology,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin-related cardiotoxicity: review of fundamental pathways of cardiovascular system injury;Cardiovascular Pathology;2024-11

2. Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management;Life Sciences;2024-02

3. Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy;International Journal of Cardiology;2023-11

4. Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity;Human & Experimental Toxicology;2023-08-01

5. Late-onset doxorubicin-induced congestive heart failure in an elderly cancer survivor: A case report;Frontiers in Cardiovascular Medicine;2023-04-25